Alkene Carboxy-Alkylation via CO<sub>2</sub><sup>•–</sup>
Herein, we introduce a new platform for alkene carboxy-alkylation. This reaction is designed around CO<sub>2</sub><sup>•-</sup> addition to alkenes followed by radical polar crossover, which enables alkylation through carbanion attack on carbonyl electrophiles. We discovered that CO<sub>2</sub><sup>•-</sup> adds to alkenes faster than it reduces carbonyl electrophiles and that this reactivity can be exploited by accessing CO<sub>2</sub><sup>•-</sup> via hydrogen atom transfer from formate. This photocatalytic system transforms vinylarenes and carbonyl compounds into a diverse array of substituted γ-lactone products. Furthermore, indoles can be engaged through dearomative carboxy-alkylation, delivering medicinally relevant C(sp<sup>3</sup>)-rich heterocyclic scaffolds. Mechanistic studies reveal that the active photocatalyst is generated <i>in situ</i> through a photochemically induced reaction between the precatalyst and DMSO. Overall, we have developed a three-component alkene carboxy-alkylation reaction enabled by the use of formate as the CO<sub>2</sub><sup>•-</sup> precursor.
Authors
- Myriam Mikhael (ORCID: https://orcid.org/0000-0003-4895-6119)
- Sara N. Alektiar (ORCID: https://orcid.org/0000-0003-4283-468X)
- Yun Dang (ORCID: https://orcid.org/0000-0003-4279-901X)
- Ilia A. Guzei (ORCID: https://orcid.org/0000-0003-1976-7386)
- Charles S. Yeung (ORCID: https://orcid.org/0000-0001-7320-7190)
- Zachary K. Wickens (ORCID: https://orcid.org/0000-0002-5733-5288)
- Alyah F. Chmiel (ORCID: https://orcid.org/0000-0002-4859-6689)
- Jimin Han (ORCID: https://orcid.org/0009-0008-5936-5270)
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- University of Wisconsin–Madison (US)
Publication Details
- Journal
- Journal of the American Chemical Society
- Published
- 2024-12-12
- DOI
- https://doi.org/10.1021/jacs.4c14421
- Citations
- 25
- Primary Topic
- Carbon dioxide utilization in catalysis
- Type
- article
- Field-Weighted Citation Impact
- 4.46
Funders
- Merck
- National Institutes of Health
- National Institute of General Medical Sciences
- Division of Chemistry